Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Breban

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Joint Bone Spine|January 17, 2022
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritisDaniel Wendling, Sophie Hecquet, Olivier Fogel, et al.
Frontiers in Immunology|February 23, 2023
Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responsesQuentin Jouhault, Bilade Cherqaoui, Aude Jobart-Malfait, et al.
Joint Bone Spine|July 5, 2022
Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344]Daniel Wendling, Sophie Hecquet, Olivier Fogel, et al.
RMD Open|July 18, 2025
When generative artificial intelligence answers to Google Trends about spondyloarthritis: what does a French expert panel think about it?Frank Verhoeven, Olivier Fakih, Corinne Miceli-Richard, et al.
Joint Bone Spine|May 25, 2024
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshopDaniel Wendling, Maxime Breban, Félicie Costantino, et al.
Genome Biology|July 29, 2017
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitisChengping Wen, Zhijun Zheng, Tiejuan Shao, et al.
Genome Biology|November 10, 2017
Correction to: Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitisChengping Wen, Zhijun Zheng, Tiejuan Shao, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safetyFrank Heldmann, Xenofon Baraliakos, Uta Kiltz, et al.
Joint Bone Spine|July 21, 2015
Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohortMaxime Dougados, Adrien Etcheto, Anna Molto, et al.
Joint Bone Spine|April 5, 2011
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patientsMaxime Dougados, Maria-Antonietta d'Agostino, Joëlle Benessiano, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Joint Bone Spine|January 17, 2022
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritisDaniel Wendling, Sophie Hecquet, Olivier Fogel, et al.
Frontiers in Immunology|February 23, 2023
Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responsesQuentin Jouhault, Bilade Cherqaoui, Aude Jobart-Malfait, et al.
Joint Bone Spine|July 5, 2022
Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344]Daniel Wendling, Sophie Hecquet, Olivier Fogel, et al.
RMD Open|July 18, 2025
When generative artificial intelligence answers to Google Trends about spondyloarthritis: what does a French expert panel think about it?Frank Verhoeven, Olivier Fakih, Corinne Miceli-Richard, et al.
Joint Bone Spine|May 25, 2024
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshopDaniel Wendling, Maxime Breban, Félicie Costantino, et al.
Genome Biology|July 29, 2017
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitisChengping Wen, Zhijun Zheng, Tiejuan Shao, et al.
Genome Biology|November 10, 2017
Correction to: Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitisChengping Wen, Zhijun Zheng, Tiejuan Shao, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safetyFrank Heldmann, Xenofon Baraliakos, Uta Kiltz, et al.
Joint Bone Spine|July 21, 2015
Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohortMaxime Dougados, Adrien Etcheto, Anna Molto, et al.
Joint Bone Spine|April 5, 2011
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patientsMaxime Dougados, Maria-Antonietta d'Agostino, Joëlle Benessiano, et al.
Pageof 15